NON-ANIMAL NAVIGATOR

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Jul 2025 filing date already counts against anyone who files later.

Record

Serial number

99270216

Mark type

Stylized text

Filed

07 Jul 2025

Published for opposition

17 Feb 2026

Attorney of record

Carrie Webb Olson

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downdoadable computer software for drug development research; Downloadable software for use in modeling, simulating, and predicting pharmacokinetic and toxicological outcomes to support drug development and regulatory submissions; Downloadable computer software for use in evaluating preclinical safety using in vitro, in silico, and biosimulation methodologies.
• Class 042 — Scientific and technological services: Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Technological consultation in the field of computer networking; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Providing online non-downloadable software for data integration; Providing online non-downloadable software for creating networks of disparate data; Providing online non-downloadable software using artificial intelligence for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research; Consultancy in the fields of information technology, pharmacology and software design; Software as a service (SAAS) featuring software for modeling, simulating, and analyzing biological and pharmacological data to support drug development; Providing temporary use of non-downloadable software for predicting preclinical safety outcomes using biosimulation and artificial intelligence; Consulting services in the field of scientific and technological research related to testing alternatives for pharmaceuticals; Consulting services in the field of pharmaceutical drug development, namely, advising on testing methods, toxicological data interpretation, and regulatory strategy related to preclinical safety assessment

Owner

• Certara USA, Inc., Radnor, PA, US
• Certara USA, Inc., Radnor, PA, US

Prosecution history

• 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 17 Feb 2026 — PUBLISHED FOR OPPOSITION
• 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 20 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 14 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
• 13 Jan 2026 — ASSIGNED TO LIE
• 13 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 13 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
• 13 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
• 09 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 09 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 09 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 25 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 25 Nov 2025 — NON-FINAL ACTION E-MAILED
• 25 Nov 2025 — NON-FINAL ACTION WRITTEN